Mette Haugen

Hu and Voltage-Gated Calcium Channel (VGCC) Antibodies Related to the Prognosis of Small-Cell Lung Cancer

Sissel E. Monstad, L. Drivsholm, Anette Storstein et al. · Journal of Clinical Oncology · 2004 · 96 citations

Paraneoplastic CDR2 and CDR2L antibodies affect Purkinje cell calcium homeostasis

Manja Schubert, Debabrata Panja, Mette Haugen et al. · Acta Neuropathologica · 2014 · 64 citations · Full text

CDR2L Is the Major Yo Antibody Target in Paraneoplastic Cerebellar Degeneration

Torbjørn Kråkenes, Ida Herdlevær, Margrethe Raspotnig et al. · Annals of Neurology · 2019 · 63 citations · Full text

Pcd Patients, Amyotrophic Lateral Sclerosis, Cdr2l Antibodies +15

CDR2L Antibodies: A New Player in Paraneoplastic Cerebellar Degeneration

Tilo Wolf Eichler, Cecilie Totland, Mette Haugen et al. · PLoS ONE · 2013 · 55 citations · Full text

Cerebellar degeneration-related proteins 2 and 2-like are present in ovarian cancer in patients with and without Yo antibodies

Margrethe Raspotnig, Mette Haugen, Maria Thorsteinsdottir et al. · Cancer Immunology Immunotherapy · 2017 · 36 citations · Full text

Malignant Disease, Yo Antibodies, Pathology +5